Prospective, multicentric, randomized, open, comparative phase IV study evaluating the efficacy and safety of the dosage adjustment of Aprovel (irbesartan) in hypertensive outpatients in current clinical practice.

Trial Profile

Prospective, multicentric, randomized, open, comparative phase IV study evaluating the efficacy and safety of the dosage adjustment of Aprovel (irbesartan) in hypertensive outpatients in current clinical practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 24 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top